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The effect of the administration of 20mg/100g aqueous extract of the leaves of Tridax 
procumbens on the packed cell volume (PCV), daily weight gain, plasma lipid profiles and 
atherogenic indices of rats fed 1g/100g cholesterol, was investigated. The mean daily weight 
gain and plasma concentrations of triglyceride, LDL-, VLDL- and total cholesterol, as well as 
the atherogenic indices [Cardiac Risk Ratio (CRR), Atherogenic Coefficient (AC) and 
Atherogenic Index of Plasma (AIP)] of the treated animals were all significantly lower 
(p<0.05) than those of the test control and control. The PCV and plasma HDL-cholesterol 
level of the treated animals was significantly higher (p<0.05) than that of the test control, 
although lower than that of the control. These results suggest a possible protective role of the 
extract against the development of cardiovascular diseases, as well as dyslipidemic 
conditions, whether primary or secondary to diabetes mellitus, hypertension and obesity 
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About 80% of the world’s population depends 
on plants to treat many common ailments, and 
30% of modern conventional drugs are derived 
from plant sources. Herbs have been used 
safely and effectively for many centuries, and 
are free of most of the side effects associated 
with synthetic drugs
1
. Tridax procumbens Linn 
(compositae), a grass commonly found in 
tropics is traditionally used in the South 
Eastern and South Western Nigeria, for 
stopping bleeding, treating diarrhea, malaria 
and stomachache, and reducing blood 
pressure
2,3
. Edeoga et al.
2
 demonstrated the 
hypotensive effect, while Hemalatha
4
 
demonstrated the antihepatotoxic and 
antioxidant defense potential of aqueous 
extracts of the leaves of Tridax procumbens on 
rats. 
 
Dyslipidemia is associated with hypertension, 
diabetes mellitus and obesity, and is one of the 
major risk factors for the development of 
cardiovascular disease
5-9
. Therefore, the 
present study was designed to investigate the 
effect of aqueous extracts of Tridax 
procumbens on the plasma lipid profile of 
cholesterol-loaded rats with a view to finding 
any possible cue to the molecular basis of its 
antihypertensive action.  
 
MATERIALS AND METHODS 
 
Collection of Animals and Preparation of 
the Leaves 
Albino rats were collected from the animal 
house of the Department of Biochemistry, 
University of Port Harcourt, Port Harcourt, 
Nigeria. The plants were collected from 
behind the Ofrima Hall Complex of University 
of Port Harcourt, Port Harcourt, Nigeria. After 
due identification at the Herbarium of the 
Department of Plant Science and 
Biotechnology, University of Port Harcourt, 
Nigeria, their leaves were collected, rid of dirt, 
oven dried at 55
0
C and ground into powder. 
The resultant powder was soaked in boiled 
distilled water for 12h, after which the 
resultant mixture was filtered and the filtrate, 
hereinafter referred to as the aqueous extract 
was stored for subsequent use. A known 
volume of this extract was evaporated to 
dryness, and the weight of the residue used to 
determine the concentration of the filtrate, 
which was in turn used to determine the dose 
of administration of the extract to the test 
animals. 
 
Experimental Design and Composition of 
Diet 
The rats were randomly sorted into three 
groups of five animals each, so that the 
average weight difference was ±1.8g.  The 
animals were individually housed in plastic 
metabolic cages. After a one-week 
acclimatization period on guinea growers 
mash (Bendel Feed and Flour Mills Ltd., Ewu, 
Nigeria), the treatment commenced and lasted 
for a week. The test received daily by intra-
gastric gavages, 1g/100g body weight of 
cholesterol and 20mg/100g body weight of the 
extract; the test-control received daily by intra-
gastric gavages, 1g/100g body weight of 
cholesterol; while the control group received 
appropriate volumes of water by the same 
route. The dosage of administration of the 
extract was adapted from Bhagwat et al
10
. The 
animals were allowed food and water ad 
libitum. At the end of the treatment period the 
rats were weighed and anaesthetized by intra-
peritoneal injection of 5mg/kg body weight of 
25% Urethane saline solution. While under 
anesthesia blood was collected from each rat 
via heart puncture and transferred into heparin 
sample bottles after which they were 
painlessly sacrificed. 
 
Determination of the Plasma Lipid 
Profiles/Indices 
Plasma total cholesterol (TC), HDL-
cholesterol (HDLC) and triglyceride (TG) 
were assayed enzymatically with commercial 
test kits (Randox Laboratories, Crumlin, 
England). Plasma LDL-cholesterol was 





LDLC = TC – HDLC – TG/2.2. 
VLDLC = TG/2.2. 
 





Cardiac Risk Ratio (CRR) =TC/HDLC 
Atherogenic Coefficient (AC) = (TC – 
HDLC)/HDLC  





Statistical Analysis of Data 
All values are quoted as the mean ± SD. The 
values of the various parameters for the 
control, test control and test groups were 
analyzed for statistical significant differences 
using the student’s t-test. P<0.05 was assumed 




Table 1 shows the effect of aqueous extracts of 
Tridax procumbens on the mean daily weight 
gain and PCV of cholesterol loaded rats. The 
mean daily weight gain of the test animals was 
significantly lower (p<0.05) than that of the 
test control and the control groups. The PCV 
of the animals in the test group was 
significantly higher (p<0.05) than that of the 
test control, and significantly lower than that 
of the control. The effect of the aqueous 
extract of Tridax procumbens on plasma lipid 
profiles of cholesterol loaded rats is shown in 
Table 2.  
 
The plasma total triglyceride, LDL-, VLDL- 
and total cholesterol levels of the treated 
animals was significantly lower (p<0.05) than 
those of the test control and control. The 
plasma HDL-cholesterol levels of the treated 
animals was significantly lower (p<0.05) than 
that of the test control, although significantly 
lower than that of the control. The atherogenic 
indices: cardiac risk ratio (CRR), atherogenic 
coefficient (AC) and atherogenic index of 
plasma (AIP), of the treated animals was 
significantly lower (p<0.05) than those of the 




The PCV of the animals in the test group was 
significantly higher than that of the test 
control, and significantly lower than that of the 
control (Table 1). This implies that the extract 
significantly protected the animals against the 
hypercholesterolemia induced lowering of 
PCV, even though it could not restore it to 
normal level. Weight loss helps improve and 
control coronary risk incidence, diabetes 
mellitus, dyslipidemia, hypertension, obesity 
and physical functioning
15-18
, and is one of the 
strategies for increasing low HDL-C levels
19
, 
as well as improving the insulin resistance
18
. 
Therefore, the significantly low mean daily 
weight gain produced by the extract, in the test 
animals implies that it may be useful in the 




Table 1: Effect of aqueous extract of Tridax procumbens on the PCV and mean daily weight gain of 
cholesterol loaded rats. 













      Values are means ± SD, n=4 per group. Entries with different superscripts are significantly different at p<0.05. 
 
 
Table 2: Effect of aqueous extract of Tridax procumbens on the plasma lipid profile of cholesterol loaded rats. 
Parameter  Concentration (mmol/L) 
Control Test-control Test 






























Values are means ± SD, n=4 per group. Entries with different superscripts are significantly different at p<0.05. 
 
Table 3: Effect of aqueous extract of Tridax procumbens on the atherogenic indices of cholesterol loaded rats. 
Parameter  Control Test-control Test 























High plasma concentrations of triglyceride is 
both an independent and synergistic risk factor 
for cardiovascular diseases
8,14,20 
and is often 
found in hypertension
5
, abnormal lipoprotein 
metabolism, obesity, insulin resistance and 
diabetes mellitus
6,9,18,20
. In this study, the 
extract produced a significantly lower plasma 
triglyceride level. Another well-established 
and recognized risk factor for developing 
atherosclerosis and other cardiovascular 
diseases is increased plasma total cholesterol 
level
21
. It is often found in hypertension
5
. It 
therefore follows that a reduction in plasma 
total cholesterol level will reduce the risk of 
cardiovascular diseases. Thus, the significantly 
lower plasma total cholesterol levels produced 
by the extract, connotes the ability of the 
extract to protect against cardiovascular 
diseases. 
 
High plasma concentrations of LDL and 
VLDL cholesterol is a risk factor for 
cardiovascular disease
21,22 








. Decreases in plasma LDL 
cholesterol have been considered to reduce 
risk of coronary heart disease
7
. In this study, 
we observed a significantly lower plasma LDL 
and VLDL cholesterol levels in the treated 
animals.  
 
Another major and well-established risk factor 
for the development of cardiovascular diseases 
is decreased plasma concentrations of HDL 
cholesterol
7,8,13,22








. Clinical data show that increase in 





High HDL exerts a protective effect by 
decreasing the rate of entry of cholesterol into 
the cell via LDL and increasing the rate of 
cholesterol release from the cell
23 
 by 
enhancing reverse cholesterol transport by 
scavenging excess cholesterol from peripheral 
tissues followed by esterification through 
lecithin: cholesterol acyltransferase and 
delivering it to the liver and steroidogenic 
organs for subsequent synthesis of bile acids 
and lipoproteins and eventual elimination from 
the body
19,21
; and inhibiting the oxidation of 
LDL as well as the atherogenic effects of 






In this study, the extract produced an increased 
plasma HDL cholesterol concentration.  
 
Atherogenic indices are powerful indicators of 
the risk of heart disease: the higher the value, 
the higher the risk of developing 
cardiovascular disease and vice versa
8,12-14,25
. 
In this study, we observed that the extract 
significantly reduced atherogenic indices 
CRR, AC and AIP. Low atherogenic indices 




In conclusion, our results suggest a possible 
protective role of the extract against the 
development of atherosclerosis and coronary 
heart disease, as well as the dyslipidemic 
conditions that characterize diabetes mellitus, 
hypertension, metabolic syndrome and obesity. 
It also suggests that the extract can help 
manage the dyslipidemic conditions
26 
that 
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